• Specialty Pharmaceuticals 
  • Digital Health 
  • Biotech 

Research Coverage 

  • Harrow Health, Inc. (HROW) 
  • OptimizeRx Corporation (OPRX)
  • TG Therapeutics, Inc. (TGTX) 


Sahil Kazmi is a Research Analyst at B. Riley Securities.

B. Riley Securities provides a full suite of investment banking, corporate finance, advisory, research, and sales and trading services. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. B. Riley is nationally recognized and highly ranked for its proprietary small-cap equity research. B. Riley Securities formerly operated as B. Riley FBR following the merger of B. Riley & Co. and FBR & Co.